Holen Sie sich die Stockscreener-App
60.05
1.12%
-0.68
Handel nachbörslich:
60.05
Schlusskurs vom Vortag:
$60.73
Offen:
$60.72
24-Stunden-Volumen:
264.41K
Relative Volume:
0.51
Marktkapitalisierung:
$1.73B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$131.74M
KGV:
14.26
EPS:
4.21
Netto-Cashflow:
$166.13M
1W Leistung:
+7.40%
1M Leistung:
+16.08%
6M Leistung:
-20.62%
1J Leistung:
-17.51%
1-Tages-Spanne:
$59.44
$60.85
1-Wochen-Bereich:
$54.83
$61.08
52-Wochen-Spanne:
$46.00
$78.58
Conmed Corp Stock (CNMD) Company Profile
Firmenname
Conmed Corp
Sektor
Branche
Telefon
727-214-2974
Adresse
11311 CONCEPT BOULEVARD, LARGO, NY
Vergleichen Sie CNMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
60.05 | 1.73B | 1.29B | 131.74M | 166.13M | 4.21 |
|
ABT
Abbott Laboratories
|
129.05 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.53 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.11 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.50 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-02-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Bestätigt | Needham | Buy |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2023-03-27 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-10-06 | Hochstufung | Needham | Hold → Buy |
| 2021-07-15 | Eingeleitet | UBS | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2019-11-26 | Herabstufung | Needham | Buy → Hold |
| 2019-11-12 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-31 | Bestätigt | Needham | Buy |
| 2019-10-04 | Bestätigt | Needham | Buy |
| 2019-08-22 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Eingeleitet | Stifel | Buy |
| 2019-04-16 | Bestätigt | Needham | Buy |
| 2019-01-23 | Bestätigt | Needham | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-07 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-02-01 | Bestätigt | Needham | Buy |
| 2017-07-27 | Bestätigt | Needham | Buy |
| 2017-04-27 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Bestätigt | Needham | Buy |
| 2016-11-18 | Bestätigt | Needham | Buy |
| 2016-07-28 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Bestätigt | Needham | Buy |
| 2015-10-22 | Bestätigt | Northland Capital | Market Perform |
Alle ansehen
Conmed Corp Aktie (CNMD) Neueste Nachrichten
Dean Capital Management Increases Stake in CONMED Co. (NYSE:CNMD) - MarketBeat
First Trust Advisors LP Raises Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Brevan Howard Capital Management LP Grows Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Axa S.A. Raises Position in CONMED Co. (NYSE:CNMD) - MarketBeat
ArrowMark Colorado Holdings LLC Decreases Position in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (NYSE:CNMD) Rating Lowered to “Hold” at StockNews.com - Defense World
CONMED Co. (NYSE:CNMD) Stock Holdings Raised by First Trust Advisors LP - Defense World
CONMED Co. (NYSE:CNMD) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Dimensional Fund Advisors LP Has $53.07 Million Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Insider Selling: Charles Farkas Sells 4,000 Shares of Conmed Cor - GuruFocus
PDT Partners LLC Sells 13,579 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
Decoding Conmed Corp (CNMD): A Strategic SWOT Insight - GuruFocus
CONMED (NYSE:CNMD) Issues Earnings Results - MarketBeat
CONMED (NYSE:CNMD) Given New $61.00 Price Target at Needham & Company LLC - MarketBeat
JPMorgan Chase & Co. Issues Pessimistic Forecast for CONMED (NYSE:CNMD) Stock Price - Defense World
Earnest Partners LLC Acquires 25,876 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (NYSE:CNMD) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
CNMD’s 52-Week Rollercoaster: From $46.00 to $78.58 – What’s Next for Investors? - investchronicle.com
Why Conmed (CNMD) is a Top Value Stock for the Long-Term - Yahoo Finance
CONMED Corporation (NYSE:CNMD) Q1 2025 Earnings Call Transcript - Insider Monkey
Conmed (CNMD) Target Price Lowered by Wells Fargo Analyst | CNMD Stock News - GuruFocus
JP Morgan Revises Price Target for Conmed (CNMD) to $58 | CNMD S - GuruFocus
Conmed Corp (CNMD) can make a big difference with a little luck - Sete News
Conmed (CNMD) Analyst Rating Update: Price Target Lowered | CNMD Stock News - GuruFocus
CONMED Corp SEC 10-Q Report - TradingView
Conmed (CNMD) Target Price Adjusted by Analyst Amid Supply Chain - GuruFocus
Conmed (CNMD) Target Price Adjusted by Analyst Amid Supply Chain Challenges | CNMD Stock News - GuruFocus
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook - Yahoo Finance
Breaking Down Conmed: 6 Analysts Share Their Views - Benzinga
Conmed (CNMD) Target Price Reduced by Wells Fargo Analyst | CNMD Stock News - GuruFocus
CONMED (CNMD) Reports Strong Q1 Revenue Surpassing Estimates | C - GuruFocus
Conmed: Q1 Earnings Snapshot - MySA
Conmed Corp [CNMD] Insider Activity: An Update for Investors - knoxdaily.com
Conmed Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: ConMed’s Q1 2025 earnings miss EPS forecasts, stock rises - Investing.com
CONMED beats Q1 revenue estimates, raises full-year outlook; shares jump By Investing.com - Investing.com South Africa
CONMED beats Q1 revenue estimates, raises full-year outlook; shares jump - Investing.com Canada
CONMED Q1 2025 slides: Revenue growth continues amid GAAP earnings pressure - Investing.com Canada
CONMED Corporation Announces First Quarter 2025 Financial Results - Stock Titan
CONMED (NYSE:CNMD) Rating Lowered to "Hold" at Stifel Nicolaus - MarketBeat
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
CONMED (NYSE:CNMD) Downgraded by Stifel Nicolaus to “Hold” - Defense World
CONMED (CNMD) Downgraded by Stifel Due to Sales Decline - GuruFocus
What To Expect From CONMED’s (CNMD) Q1 Earnings - Barchart.com
Orthopedic Biomaterial Market Overall Study Report 2025-2032 | - openPR.com
Conmed stock rating cut to hold at Stifel, target drops to $55 - Investing.com Canada
Conmed stock rating cut to hold at Stifel, target drops to $55 By Investing.com - Investing.com South Africa
Conmed (CNMD) Downgraded by Stifel Amid Economic Concerns | CNMD Stock News - GuruFocus
CONMED (NYSE:CNMD) Sets New 1-Year LowWhat's Next? - MarketBeat
Natixis Has $7.80 Million Stock Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Fuller & Thaler Asset Management Inc. Takes $59.05 Million Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Finanzdaten der Conmed Corp-Aktie (CNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):